<?xml version="1.0" encoding="UTF-8"?>
<p id="Par28">Children have a higher incidence of influenza and a higher hospitalization rate than adults
 <sup>
  <xref ref-type="bibr" rid="CR27">27</xref>
 </sup> and are an important reservoir in its transmission
 <sup>
  <xref ref-type="bibr" rid="CR6">6</xref>,
  <xref ref-type="bibr" rid="CR28">28</xref>
 </sup>, generating a high socio-economic impact due to school and work absenteeism, and to greater pharmaceutical expenditure and use of health resources
 <sup>
  <xref ref-type="bibr" rid="CR6">6</xref>
 </sup>. For these reasons, recommendations on the inclusion of routine childhood vaccines in vaccination programs, especially in young children, are gaining weight. European countries such as Austria, Finland, Latvia and Slovakia have introduced routine influenza vaccination for all children from 6–7 months, while in the United Kingdom it is administered systematically from 2 years of age and before this in children at risk of influenza
 <sup>
  <xref ref-type="bibr" rid="CR29">29</xref>–
  <xref ref-type="bibr" rid="CR31">31</xref>
 </sup>. The United States, Canada and Japan have also included influenza vaccination from 6 months of age
 <sup>
  <xref ref-type="bibr" rid="CR32">32</xref>–
  <xref ref-type="bibr" rid="CR34">34</xref>
 </sup>. Sugaya 
 <italic>et al</italic>. evaluated the inclusion of influenza vaccination in the 2013–2016 seasons in children aged 6 months-15 years in Japan and found a vaccine effectiveness (VE) in disease prevention of 51% for influenza A and 32% for influenza B; the VE in preventing hospitalizations was 52% for influenza A and 28% for influenza B
 <sup>
  <xref ref-type="bibr" rid="CR35">35</xref>
 </sup>.
</p>
